Enclomiphene Citrate Cost in Minnesota 2026

What Does Enclomiphene Citrate Cost in Minnesota in 2026?

The dominant price point for enclomiphene citrate in Minnesota is approximately $90 per month through a licensed 503A compounding pharmacy. Branded or commercial-grade formulations carry a higher list price, but most patients in 2026 access the drug through compounding channels because no finished-dose commercial product is widely stocked at major retail chains in Minnesota.

Enclomiphene is the trans-isomer of clomiphene. It selectively blocks estrogen receptors in the hypothalamus, raising gonadotropin-releasing hormone (GnRH) pulse frequency and driving luteinizing hormone (LH) and follicle-stimulating hormone (FSH) upward, which in turn stimulates endogenous testosterone production. Because it does not suppress the hypothalamic-pituitary-gonadal (HPG) axis the way exogenous testosterone does, it preserves spermatogenesis, a feature that makes it particularly relevant for men with secondary hypogonadism who want to maintain fertility [1].

In the randomized, double-blind trial by Kim et al. (BJU Int 2016, N=124), enclomiphene citrate at 12.5 mg and 25 mg daily raised serum testosterone from a mean baseline of roughly 250 ng/dL to over 400 ng/dL after 3 months, while also maintaining sperm counts above baseline, a result that sharply contrasts with exogenous testosterone therapy, which suppresses sperm production in the majority of men [1]. That study used 12.5 mg and 25 mg oral doses, which correspond directly to the capsule strengths most Minnesota compounding pharmacies prepare today.

The FDA's prescribing guidance for enclomiphene reinforces daily oral dosing and clinical monitoring of testosterone, LH, FSH, and hematocrit at baseline and follow-up intervals [2]. Physicians in Minnesota typically order a comprehensive male hormone panel before initiating therapy and recheck levels at 6 to 8 weeks.

Price variation across Minnesota cities is modest. Twin Cities-area 503A pharmacies generally charge $85 to $95 per month. Outstate pharmacies (Duluth, Rochester, St. Cloud) report similar ranges, though some rural patients use mail-order 503A pharmacies licensed in Minnesota, which ship directly and charge comparable rates.

How Minnesota Medicaid Covers Enclomiphene Citrate

Minnesota Medicaid (Medical Assistance) covers enclomiphene citrate for secondary hypogonadism with a prior authorization. The off-label designation for this indication does not automatically exclude coverage; Minnesota's Drug Formulary Committee reviews requests on clinical merit, and prior authorization approval rates for documented hypogonadism are meaningful when labs (serum testosterone <300 ng/dL on two morning draws) and a physician attestation accompany the request [3].

The prior authorization process typically requires: a documented diagnosis of secondary (hypogonadotropic) hypogonadism, two fasting morning total testosterone levels below 300 ng/dL, LH and FSH levels confirming the secondary rather than primary pattern, and a prescribing physician's clinical note. Minnesota's Medicaid preferred drug list (PDL) places enclomiphene in a non-preferred tier, so even after PA approval, co-pays may apply depending on the enrollee's specific Medical Assistance plan [4].

The Endocrine Society's 2018 clinical practice guideline states: "We recommend against making a diagnosis of androgen deficiency in men with acute or subacute illness and suggest against universal screening for androgen deficiency." [5] This language matters for PA submissions because it signals that Medicaid reviewers will expect documented, stable hypogonadism, not a single low testosterone drawn during illness or stress.

For MinnesotaCare enrollees (the subsidized plan for adults above Medicaid income thresholds), the coverage pathway mirrors Medical Assistance, though the co-pay structure differs. Patients should request a formulary exception letter from their prescriber in addition to the standard PA form to reduce denial rates [4].

Is Compounded Enclomiphene Citrate Legal in Minnesota?

Compounded enclomiphene citrate is legal in Minnesota when prepared by a state-licensed 503A pharmacy operating under Chapter 151 of Minnesota Statutes and Section 503A of the Federal Food, Drug, and Cosmetic Act [6]. The 503A designation means the pharmacy compounds on a patient-specific basis after receiving a valid prescription from a licensed prescriber. No bulk manufacturing or anticipatory compounding without a prescription is permitted under this framework.

The FDA's Memorandum on Essentially a Copy (EAC) policy creates a nuance: once a commercially available finished-dose enclomiphene product holds FDA approval and is readily obtainable, 503A pharmacies may face restrictions on compounding that same formulation unless a prescriber documents a clinical reason why the commercial product is inappropriate for a specific patient [2]. As of early 2026, availability of the commercial product at Minnesota retail pharmacies remains limited, so 503A compounding continues to be the practical access route for most patients.

Minnesota's Board of Pharmacy actively audits 503A compounders for compliance with USP Chapter 795 (non-sterile preparations) standards, which govern enclomiphene capsules and tablets [6]. Patients should verify that their chosen pharmacy holds a current Minnesota pharmacy license and can provide a certificate of analysis (COA) confirming identity, potency, and absence of contaminants for each batch.

A 503B outsourcing facility (which compounds without patient-specific prescriptions) may also supply enclomiphene to Minnesota clinics and telehealth providers if the compound appears on FDA's 503B category list. Patients receiving enclomiphene through a telehealth platform should ask whether their dispensing pharmacy is 503A or 503B and confirm the COA is available on request [7].

Enclomiphene Citrate and Private Insurance in Minnesota

Private insurance coverage for enclomiphene citrate in Minnesota varies widely by plan. Major Minnesota-based insurers, including Blue Cross and Blue Shield of Minnesota, HealthPartners, and Medica, do not uniformly list enclomiphene on their standard formularies because the drug's commercial availability has been inconsistent. Most plans classify it as a specialty or non-formulary item requiring prior authorization and sometimes a step-therapy requirement (typically a trial of clomiphene citrate or testosterone replacement therapy first) [8].

Step-therapy waivers are available under Minnesota Statutes Section 62Q.184, which limits the conditions under which a health plan can require step therapy for a drug that a prescriber has deemed clinically appropriate. A physician who documents that testosterone replacement therapy is contraindicated (such as in a man trying to conceive) may successfully argue that bypassing the step-therapy requirement is medically necessary [9].

The American Urological Association's 2018 guideline on male infertility supports the use of FSH-stimulating agents, including selective estrogen receptor modulators such as enclomiphene, in men with hypogonadotropic hypogonadism who wish to preserve fertility [10]. Submitting this guideline passage alongside a prior authorization appeal can strengthen the case with a commercial insurer's pharmacy and therapeutics committee.

Out-of-pocket caps under ACA-compliant plans mean that even non-formulary drugs count toward the annual deductible and out-of-pocket maximum once the insurer processes the claim, even at the non-formulary tier. For a plan with a $4,000 out-of-pocket maximum, the practical cost burden over a full treatment year depends heavily on whether the PA is approved and at which tier.

The Cheapest Ways to Get Enclomiphene Citrate in Minnesota

For patients without insurance coverage or with high co-pays, several cost-reduction strategies apply specifically in Minnesota.

Telehealth bundle pricing. Many telehealth platforms serving Minnesota bundle the prescriber visit, lab requisition, and compounded medication into a single monthly fee. These bundles typically run $100 to $150 per month all-in, which compares favorably to paying separately for a specialist visit, labs, and pharmacy. The convenience also reduces travel burden for patients in outstate areas [11].

GoodRx and pharmacy discount cards. GoodRx prices for enclomiphene at Minnesota pharmacies that stock it range from approximately $80 to $120 per month for a 30-day supply of the 12.5 mg or 25 mg dose. These prices fluctuate by zip code and pharmacy chain, so checking multiple pharmacies in the same metro area often reveals a 10% to 20% spread [12].

Manufacturer and compounding savings cards. Some 503A compounding pharmacies in Minnesota offer in-house loyalty pricing for patients who commit to a 3-month or 6-month supply, reducing the per-month cost by $10 to $20. Savings cards tied to commercial enclomiphene products may also apply; patients should ask their telehealth provider or prescriber whether a current savings card is available [2].

Minnesota Rx Connect. The state's pharmaceutical assistance program (Minnesota Rx Connect) primarily targets seniors and lower-income adults and focuses on maintenance medications. Enclomiphene does not currently appear on its covered drug list, but patients who meet income criteria may use Rx Connect to offset co-pays on associated monitoring labs, reducing overall treatment costs [13].

Splitting the telehealth visit cost. Because enclomiphene is a prescription-only drug, the prescriber visit is unavoidable. However, a telehealth visit for hormone optimization in Minnesota averages $50 to $100 for an initial consultation and $30 to $60 for follow-up, compared to $150 to $300+ for an in-person endocrinology or urology office visit. Over a 12-month treatment period, the telehealth route may save $600 to $1 to 800 in visit costs alone [11].

Clinical Monitoring Costs to Budget For

The drug cost is only one part of the total treatment expense. A full hormone panel (total testosterone, free testosterone, LH, FSH, estradiol, CBC, and metabolic panel) runs $80 to $200 at outpatient labs in Minnesota depending on whether the order goes through a hospital system or an independent lab. Quest Diagnostics and LabCorp both operate collection sites across the Twin Cities and Greater Minnesota and frequently offer cash-pay pricing that undercuts hospital lab rates by 30% to 50%.

The FDA label for enclomiphene recommends confirming testosterone response at 3 months and monitoring hematocrit to screen for erythrocytosis, a known class effect of testosterone-raising therapies [2]. Patients on enclomiphene should budget for at least two lab draws per year: one at baseline and one at the 3-month mark. At cash-pay rates, total annual lab costs might range from $160 to $400.

Bone density (DXA scan) monitoring is not required for enclomiphene at short durations, but the Endocrine Society guideline does recommend bone mineral density assessment in men with hypogonadism who have been symptomatic for more than 2 years [5]. A DXA scan in Minnesota costs $100 to $250 cash-pay and is usually covered by insurance when ordered for a documented hypogonadism diagnosis.

Enclomiphene Versus Testosterone Replacement: A Minnesota Cost Comparison

For men evaluating enclomiphene against testosterone replacement therapy (TRT), cost comparison across a 12-month horizon in Minnesota looks roughly as follows.

Enclomiphene citrate (compounded 503A): $90 per month for medication, plus $160 to $400 for labs, plus $50 to $100 for telehealth visits. Twelve-month total: approximately $1,400 to $2,100.

Testosterone cypionate (self-administered injection, compounded or generic): $30 to $60 per month for medication, plus $200 to $500 for labs (including PSA and hematocrit monitoring), plus needles, syringes, and sharps disposal. Twelve-month total: approximately $700 to $1,400. However, testosterone cypionate suppresses spermatogenesis in approximately 65% of men within 6 months and requires fertility-sparing adjuncts (hCG, FSH) if the patient wants to maintain fertility, which adds $100 to $300 per month to the TRT cost [1].

Clomiphene citrate (generic, the racemic parent compound): As low as $20 to $40 per month at generic pharmacy prices, but clomiphene contains both the enclomiphene (active) and zuclomiphene (less active, longer-acting) isomers. Some men experience more estrogen-related side effects on clomiphene than on enclomiphene because zuclomiphene accumulates over weeks [1]. The cost savings may not offset tolerability for all patients.

The STORM trial (N=145) showed that men treated with 25 mg enclomiphene daily maintained higher testosterone levels and better symptom scores at 3 months compared with those treated with 50 mg clomiphene citrate, with similar adverse-event profiles [14]. That 2013 data from Repros Therapeutics remains a reference point for formulary discussions with insurers.

Telehealth Access for Enclomiphene in Minnesota

Minnesota telehealth law (Minnesota Statutes Section 62A.671) requires that telehealth services meet the same standard of care as in-person services [9]. A prescriber in Minnesota, or a prescriber licensed in another state seeing a patient physically located in Minnesota, can prescribe enclomiphene following a synchronous audio-video consultation that includes a review of hormone labs.

Controlled-substance rules do not apply to enclomiphene, which is not a DEA scheduled substance. This simplifies the telehealth prescribing process considerably compared to, say, testosterone cypionate (Schedule III). No in-person visit is required before the initial prescription, provided the prescriber reviews relevant labs and documents a valid clinical indication [9].

Several national telehealth platforms (Maximus, Hone Health, Invigor Medical, and HealthRX's own clinical network) serve Minnesota residents and can coordinate lab draws at local Quest or LabCorp sites before the initial consult. Turnaround from first contact to receiving a prescription-in-hand typically runs 5 to 10 business days when labs are completed promptly.

Minnesota's telehealth parity law requires that insurers cover telehealth visits at the same rate as in-person visits for the same service code [9]. Patients using private insurance for their prescriber visits should confirm their plan's telehealth benefit before booking, because some plans apply the telehealth benefit only to synchronous video visits, not asynchronous messaging-based consults.

What to Ask Your Minnesota Prescriber Before Starting

Before filling a first prescription, patients should ask their prescriber four specific questions. First, which 503A pharmacy in Minnesota does the practice work with, and is a COA available? Second, what is the practice's protocol if testosterone does not rise above 400 ng/dL at the 3-month check? Third, does the practice offer a bundled pricing model that covers visits and labs, and what does that model cost per month? Fourth, if the patient's insurer requires step therapy, will the prescriber document the fertility-preservation rationale to support a step-therapy waiver?

These questions surface the total cost picture before it becomes a surprise at month three. Men who want to preserve fertility should also discuss sperm analysis at baseline, because enclomiphene's fertility advantage over TRT is most clearly demonstrated when a baseline is established first [1].

The Endocrine Society's 2018 guideline specifies: "In men with secondary hypogonadism who are interested in fertility, we suggest using gonadotropin therapy or pulsatile GnRH therapy to stimulate spermatogenesis." [5] Enclomiphene, as a selective estrogen receptor modulator that raises endogenous gonadotropins, fits within the spirit of this recommendation, and prescribers frequently cite this passage in prior authorization letters to both Medicaid and private insurers.

Patients in Minnesota should request a 90-day supply on first fill when using a 503A pharmacy, because the per-unit cost is typically lower on a 90-day order, and many compounders waive shipping fees on orders above a certain threshold. A 90-day supply at $90 per month runs $270, compared to three separate 30-day fills that may include a $10 to $15 dispensing fee each time.